scm
Lv3
375 积分
2022-05-28 加入
-
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
9天前
已完结
-
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
9天前
已关闭
-
Long-Term Retention and Clearance of Particles Inhaled by Mammalian Species
9天前
已完结
-
Association of Inhalation Toxicologists (AIT) Working Party Recommendation for Standard Delivered Dose Calculation and Expression in Non-Clinical Aerosol Inhalation Toxicology Studies with Pharmaceuticals
12天前
已完结
-
Revised guides for organ sampling and trimming in rats and mice – Part 1
12天前
已完结
-
Revised guides for organ sampling and trimming in rats and mice – Part 3
12天前
已完结
-
Revised guides for organ sampling and trimming in rats and mice – Part 2
12天前
已完结
-
Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment
20天前
已完结
-
Drug-induced crystal nephropathy: an update
20天前
已完结
-
Safety and efficacy of pegfilgrastim in children with cancer receiving myelosuppressive chemotherapy
21天前
已完结